Updated May 21, 2020

The innovation has no owner

Claim it

In response to skyrocketing demand for testing in Korea, DowGene Co., Ltd. successfully developed, tested, and started manufacturing Dow QuickFinder™-G 2019-nCoV Real-time PCR Test Kit that uses real-time reverse-transcription PCR method for the qualitative detection of RdRp, E and N gene (N1, N2) of Novel coronavirus (2019-nCoV). The product is designed to detect Novel Coronavirus (2019-nCoV) ...
SEE ALL
In response to skyrocketing demand for testing in Korea, DowGene Co., Ltd. successfully developed, tested, and started manufacturing Dow QuickFinder™-G 2019-nCoV Real-time PCR Test Kit that uses real-time reverse-transcription PCR method for the qualitative detection of RdRp, E and N gene (N1, N2) of Novel coronavirus (2019-nCoV). The product is designed to detect Novel Coronavirus (2019-nCoV) genes quickly and accurately, and rapid and accurate diagnosis can help prevent the spread of the disease by appropriately treating the infected patients. Dow QuickFinder™-G 2019-nCoV Real-Time PCR assay is a real-time RT-PCR assay intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal or oropharyngeal swab specimens from patients suspected of COVID-19 by their healthcare provider. The instrument has to be installed, calibrated and maintained according to the manufacturer’s instruction and recommendations. Optimized for use with ABI 7500 (Fast) or Bio-Rad CFX96 real-time PCR instruments and designed to provide 96 test results per run within 1 hour 40 minutes. The Dow QuickFinder™-G 2019-nCoV Real-Time PCR Kit is CE-IVD certified, approved for export by the Korean Food and Drug Administration.
SEE LESS

Stage 4: Transition to Scale

Focus Areas:

Medical Devices and Technology

Medical Devices and TechnologySEE LESS

Implemented In:

Korea, South

Korea, SouthSEE LESS

1
Country Implemented In

Milestone

Date Unknown
New Country Implemented In
Korea, South